Systemic Recombinant Human Interferon-β Treatment of Relapsing–Remitting Multiple Sclerosis: Pilot Study Analysis and Six-Year Follow-Up

Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study

PLoS ONE ◽

10.1371/journal.pone.0074111 ◽

2013 ◽

Vol 8 (8) ◽

pp. e74111 ◽

Cited By ~ 38

Author(s):

Francesco Patti ◽

Vincenzo Brescia Morra ◽

Maria Pia Amato ◽

Maria Trojano ◽

Stefano Bastianello ◽

...

Keyword(s):

Multiple Sclerosis ◽

Cognitive Impairment ◽

Interferon Β ◽

Relapsing Remitting ◽

Effects of glatiramer acetate on spasticity in previously interferon-β-treated and treatment-naive patients with relapsing-remitting multiple sclerosis: A prospective, nonrandomized, open-label, uncontrolled, observational pilot study

Clinical Therapeutics ◽

10.1016/j.clinthera.2010.06.005 ◽

2010 ◽

Vol 32 (6) ◽

pp. 1061-1066 ◽

Cited By ~ 10

Author(s):

José Eustasio Meca-Lallana ◽

Pedro de Mingo-Casado ◽

Manuel Amorin-Díaz ◽

María Luisa Martínez-Navarro ◽

Andres Fernández Barreiro

Keyword(s):

Multiple Sclerosis ◽

Pilot Study ◽

Glatiramer Acetate ◽

Interferon Β ◽

Open Label ◽

Relapsing Remitting ◽

Treatment Naïve ◽

Efficacy of Delayed-release Dimethyl Fumarate in Newly Diagnosed Patients With Relapsing-Remitting Multiple Sclerosis: Eight-Year Follow-up of an Integrated Analysis of DEFINE, CONFIRM, and ENDORSE

10.26226/morressier.59a3eda8d462b8028d895222 ◽

2017 ◽

Cited By ~ 1

Author(s):

Ralf Gold

Keyword(s):

Multiple Sclerosis ◽

Dimethyl Fumarate ◽

Integrated Analysis ◽

Newly Diagnosed ◽

Delayed Release ◽

Relapsing Remitting ◽

Contrasting responses to interferon β-1b treatment in relapsing-remitting multiple sclerosis: Does baseline interleukin-12p35 messenger RNA predict the efficacy of treatment?

Annals of Neurology ◽

10.1002/1531-8249(200009)48:3<313::aid-ana5>3.0.co;2-9 ◽

2000 ◽

Vol 48 (3) ◽

pp. 313-322 ◽

Cited By ~ 28

Author(s):

A. H. H. Van Boxel-Dezaire ◽

S. C. J. Van Trigt-Hoff ◽

J. Killestein ◽

H. M. Schrijver ◽

J. C. Van Houwelingen ◽

...

Keyword(s):

Multiple Sclerosis ◽

Messenger Rna ◽

Interferon Β ◽

Relapsing Remitting ◽

Relapsing Remitting Multiple Sclerosis ◽

Efficacy Of Treatment

Two Years Follow up of Domain Specific Cognitive Training in Relapsing Remitting Multiple Sclerosis: A Randomized Clinical Trial

Frontiers in Behavioral Neuroscience ◽

10.3389/fnbeh.2016.00028 ◽

2016 ◽

Vol 10 ◽

Cited By ~ 11

Author(s):

Flavia Mattioli ◽

Fabio Bellomi ◽

Chiara Stampatori ◽

Leandro Provinciali ◽

Laura Compagnucci ◽

...

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Cognitive Training ◽

Domain Specific ◽

Relapsing Remitting ◽

Corrigendum to “Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: 9 Years’ Follow-up of DEFINE, CONFIRM, and ENDORSE”

Therapeutic Advances in Neurological Disorders ◽

10.1177/1756286420968357 ◽

2020 ◽

Vol 13 ◽

pp. 175628642096835

Keyword(s):

Multiple Sclerosis ◽

Dimethyl Fumarate ◽

Safety And Efficacy ◽

Delayed Release ◽

Relapsing Remitting ◽

Alemtuzumab Improves Clinical and MRI Disease Activity Outcomes, Including Slowing of Brain Volume Loss, in Relapsing-remitting Multiple Sclerosis Patients Over 8 Years: Care-MS Ii Follow-up (topaz Study)

Multiple Sclerosis and Related Disorders ◽

10.1016/j.msard.2018.10.086 ◽

2018 ◽

Vol 26 ◽

pp. 258 ◽

Cited By ~ 1

Author(s):

R. Alroughani ◽

B.A. Singer ◽

S. Broadley ◽

S. Eichau ◽

H. Hartung ◽

...

Keyword(s):

Multiple Sclerosis ◽

Disease Activity ◽

Brain Volume ◽

Volume Loss ◽

Brain Volume Loss ◽

Relapsing Remitting ◽

Multiple Sclerosis Patients ◽

Corpus callosum function in verbal dichotic listening: Inferences from a longitudinal follow-up of Relapsing-Remitting Multiple Sclerosis patients

Brain and Language ◽

10.1016/j.bandl.2009.03.006 ◽

2009 ◽

Vol 110 (2) ◽

pp. 101-105 ◽

Cited By ~ 18

Author(s):

Marien Gadea ◽

Luis Marti-Bonmatí ◽

Estanislao Arana ◽

Raul Espert ◽

Alicia Salvador ◽

...

Keyword(s):

Multiple Sclerosis ◽

Corpus Callosum ◽

Dichotic Listening ◽

Relapsing Remitting ◽

Multiple Sclerosis Patients ◽

Long-term disability outcomes in relapsing-remitting multiple sclerosis: a 10-year follow-up study

Neurological Sciences ◽

10.1007/s10072-019-03878-4 ◽

2019 ◽

Vol 40 (8) ◽

pp. 1627-1636 ◽

Cited By ~ 1

Author(s):

Jelena Drulovic ◽

Jovana Ivanovic ◽

Sarlota Mesaros ◽

Vanja Martinovic ◽

Darija Kisic-Tepavcevic ◽

...

Keyword(s):

Multiple Sclerosis ◽

Follow Up Study ◽

Relapsing Remitting ◽

ENT-MS-12 questionnaire: A novel tool to investigate otolaryngology symptoms in patients with relapsing-remitting multiple sclerosis. Results from a pilot study

Multiple Sclerosis and Related Disorders ◽

10.1016/j.msard.2020.102660 ◽

2021 ◽

Vol 47 ◽

pp. 102660

Author(s):

Arianna Di Stadio ◽

Massimo Ralli ◽

Marta Altieri ◽

Michael J Brenner ◽

Laura Dipietro ◽

...

Keyword(s):

Multiple Sclerosis ◽

Pilot Study ◽

Relapsing Remitting ◽